Brigitte Marian Selected Research

caroverine (P-201)

7/2005	Suppression of tumour-promoting factors in fat-induced colon carcinogenesis by the antioxidants caroverine and ubiquinone.
1/2005	Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour- promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brigitte Marian Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 01/2003
20	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 05/2004
11	Adenoma (Adenomas) 09/2015 - 05/2003
9	Colonic Neoplasms (Colon Cancer) 01/2014 - 01/2005
6	Carcinoma (Carcinomatosis) 01/2014 - 11/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2011
4	Carcinogenesis 08/2012 - 01/2005
3	Neoplasm Metastasis (Metastasis) 11/2012 - 11/2006
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2012 - 09/2007
2	Rectal Neoplasms (Rectal Cancer) 01/2019 - 10/2016
2	Adenocarcinoma 01/2019 - 01/2014
2	Mesothelioma 01/2018 - 10/2014
2	Malignant Mesothelioma 01/2018 - 10/2014
2	Melanoma (Melanoma, Malignant) 10/2017 - 10/2011
2	Inflammation (Inflammations) 01/2017 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2015 - 04/2008
2	Ovarian Neoplasms (Ovarian Cancer) 09/2011 - 07/2009
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Intestinal Diseases (Diseases, Intestinal) 09/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Nevus (Nevi) 10/2017
1	Adenocarcinoma of Lung 08/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2016
1	Lung Neoplasms (Lung Cancer) 08/2016
1	Sarcoma (Soft Tissue Sarcoma) 09/2015
1	Infections 10/2014
1	Osteosarcoma (Osteogenic Sarcoma) 12/2012
1	Intestinal Neoplasms (Intestinal Cancer) 08/2012

Drug/Important Bio-Agent (IBA)

11	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 10/2008
7	Messenger RNA (mRNA)IBA 01/2022 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2014
6	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2008
5	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022 - 01/2014
4	LigandsIBA 01/2022 - 01/2014
4	Phosphotransferases (Kinase)IBA 01/2018 - 10/2014
4	Biological ProductsIBA 01/2014 - 07/2010
4	Pharmaceutical PreparationsIBA 12/2012 - 03/2007
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 04/2007 - 01/2005
3	hydroxide ionIBA 09/2020 - 01/2003
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020 - 12/2015
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018 - 10/2011
3	Small Interfering RNA (siRNA)IBA 12/2015 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 01/2005
3	AntioxidantsIBA 04/2008 - 07/2005
2	Cysteine (L-Cysteine)FDA Link 09/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2017
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 08/2016 - 09/2015
2	Protein Isoforms (Isoforms)IBA 12/2015 - 10/2011
2	Butyrates (Butyrate)IBA 01/2014 - 10/2005
2	Glutathione Transferase (Glutathione S-Transferase)IBA 08/2012 - 10/2005
2	EnzymesIBA 08/2012 - 03/2007
2	QuercetinIBA 08/2012 - 04/2008
2	CurcuminIBA 08/2012 - 09/2005
2	ErbB Receptors (EGF Receptor)IBA 06/2012 - 10/2008
2	Celecoxib (Celebrex)FDA Link 04/2012 - 09/2005
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 04/2012 - 09/2007
2	EKB 569IBA 09/2011 - 07/2009
2	Canertinib (CI 1033)IBA 09/2011 - 07/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 09/2005
2	Lipid PeroxidesIBA 04/2008 - 01/2005
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 04/2007 - 05/2003
2	Dietary Fats (Dietary Fat)IBA 07/2005 - 01/2005
2	caroverine (P-201)IBA 07/2005 - 01/2005
1	IntegrinsIBA 01/2022
1	SuspensionsIBA 09/2020
1	XanthonesIBA 09/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	infigratinibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Coloring Agents (Dyes)IBA 07/2019
1	Neutral RedIBA 07/2019
1	SurvivinIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2017
1	PD 173074IBA 06/2017
1	ThrombospondinsIBA 01/2017
1	Tissue ExtractsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	nintedanibIBA 08/2016
1	Endothelin A ReceptorIBA 08/2016
1	CateninsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 11/2015
1	fibroblast growth factor 18IBA 09/2015
1	Mitogen-Activated Protein KinasesIBA 10/2014
1	Dietary Fiber FDA Link 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2014
1	beta CateninIBA 01/2014
1	ciglitazoneIBA 01/2014
1	N-chlorotaurineIBA 12/2012
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 08/2012
1	Eicosapentaenoic AcidIBA 08/2012
1	Glutathione (Reduced Glutathione)IBA 08/2012

Therapy/Procedure

15	Therapeutics 07/2019 - 10/2006
3	Radiotherapy 09/2019 - 10/2014
2	Neoadjuvant Therapy 01/2019 - 10/2016
2	Drug Therapy (Chemotherapy) 10/2014 - 12/2012
2	Chemoprevention 04/2012 - 10/2005
1	Chemoradiotherapy 01/2019
1	Aftercare (After-Treatment) 01/2014